Trent G. Kamke - Jun 14, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Jun 14, 2021
Transactions value $
-$113,906
Form type
4
Date filed
6/16/2021, 04:03 PM
Previous filing
Jun 11, 2021
Next filing
Jul 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $57.3K +2.43K +22.82% $23.56 13.1K Jun 14, 2021 Direct F1
transaction LMAT Common Stock Sale -$141K -2.43K -18.58% $58.00 10.7K Jun 14, 2021 Direct F2, F3
transaction LMAT Common Stock Options Exercise $20.6K +876 +8.22% $23.56 11.5K Jun 15, 2021 Direct F1
transaction LMAT Common Stock Sale -$50.8K -876 -7.6% $58.01 10.7K Jun 15, 2021 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2.43K -26.05% $0.00 6.9K Jun 14, 2021 Common Stock 2.43K $23.56 Direct F5
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -876 -12.69% $0.00 6.03K Jun 15, 2021 Common Stock 876 $23.56 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $58.00 to $58.02. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $58.00 to $58.09. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F5 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.